Project Scope

Analyze the diagnostic landscape to access advanced molecular diagnostics for antimicrobial resistance (AMR) management focusing on hospital-acquired and respiratory infections

Challenge

Our client, a global diagnostics company specializing in advanced molecular testing that automates traditional nucleic acid tests, sought to understand the diagnostic landscape in Saudi Arabia, particularly concerning antimicrobial resistance (AMR). The client faced challenges related to limited local adoption of rapid molecular technologies, and the presence of long-term contracts with competing platforms, hindering broader adoption

Solution

Conducted thorough primary research to:

• Understand the current diagnostic landscape in relation to AMR, particularly for respiratory and hospital-acquired infections (HAIs)
• Identify the current barriers in the adoption of rapid diagnostic technologies and POC PCR for AMR management in Saudi Arabia
• Assess policies, political developments, and anticipated government priorities for HAIs and respiratory disorders
• Identify key stakeholders and top-engagement opportunities for smooth market entry

Results

We enabled our client to:

• Gain a clear understanding of the AMR diagnostic landscape in Saudi Arabia
• Bridge local data gaps to strengthen the positioning of their POC PCR diagnostics
• Identify and engage key stakeholders to drive adoption and market access
• Align their strategy with evolving policies and government priorities
• Gain actionable insights to overcome market challenges and establish a clear pathway for successful entry